What is the 13F Pro Quality Score for DVA?

13F Pro ranks DAVITA INC. (DVA) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View DVA's current score at https://13fpro.ai/company/DVA (free sign-up required for the full ranking).

Which hedge funds own the most DVA stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of DVA include BERKSHIRE HATHAWAY, BlackRock,, VANGUARD CAPITAL MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/DVA as soon as new 13F filings post.

Where does 13F Pro source DVA data?

All DAVITA INC. fundamentals and ownership data come directly from SEC EDGAR. DAVITA INC. files with the SEC under CIK 927066. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is DVA in?

DAVITA INC. (DVA) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is DVA research updated on 13F Pro?

DVA's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

DAVITA INC.(DVA)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSElarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 927066 DVA stock profile & AI dashboard →

13F Pro Quality Score

60.4/100

Rank #856 of 2,962 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

48.1/100

Profitability

50.7/100

Balance Sheet

68.0/100

Earnings Quality

88.6/100

Free Cash Flow

58.7/100

Institutional Flow

15.5/100

Revenue Scale

89.4/100

Dilution Risk

56.6/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why DVA Scores 60/100

exact factor attribution · 2026-09-11

DVA's composite is driven by scale and earnings quality, held back by institutional flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+5.9 pts

89th pct

Earnings quality

+3.9 pts

89th pct

Capital efficiency

+1.8 pts

68th pct

Free cash flow

+1.3 pts

59th pct

Shareholder dilution

+0.3 pts

57th pct

Profitability

+0.1 pts

51th pct

Revenue growth

-0.4 pts

48th pct

Earnings growth

-0.8 pts

34th pct

Institutional flow

-1.7 pts

16th pct

Latest change (2026-08-04): 58 → 59 · ↓ Revenue growth 53→43

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

DVA Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for DAVITA INC. (DVA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DVA at 60.4/100 on a 32-signal composite quality model, placing it at rank #856 of 2,962 stocks — the top half of the AI-ranked universe. DVA scores in the top quartile across revenue scale (89.4), earnings quality (88.6). Areas of concern include institutional flow (15.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), DAVITA INC. reports quarterly revenue of $3.6B, net income of $265.4M, an operating margin of 16.3%. Top institutional holders of DVA by reported 13-F value include BERKSHIRE HATHAWAY, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. DVA trades on the NYSE exchange and files with the SEC under CIK 927066. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DAVITA INC. directly from SEC EDGAR. DAVITA INC.'s 13F Pro composite quality score has ranged between 48 and 66 since 2021, currently 60.4 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about DAVITA INC.

Quirks, history, and lore behind DVA — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · large-cap · listed on the NYSE · headquartered in Colorado.
2
The Numbers
Revenue of roughly $12 billion a year, operating thousands of outpatient centers across the country and serving hundreds of thousands of patients.
3
The History
The company emerged from bankruptcy in the early 2000s, rebranded with a new name, and went on to become one of the largest independent operators in its niche treatment category.
4
The Secret
Its business depends almost entirely on government reimbursement — Medicare and Medicaid foot most of the bill, making regulatory decisions an existential sport.
5
The Lore
Warren Buffett's Berkshire Hathaway has held a significant stake, and the company famously calls its employees "teammates" and its centers "villages" — a culture unusually warm for a medical giant.
6
The Giveaway
Its name is a clever pun on "vita" (life), it runs more kidney dialysis clinics than almost anyone on Earth, and it keeps roughly 200,000 patients alive three times a week.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$3.6B

Net Income

Q2 2026

$265.4M

Free Cash Flow

Q2 2026

$320.3M

Operating Margin

Q2 2026

16.3%

ROIC

Q2 2026

23.1%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+6.5% YoY

$13.64BFY 2025

FY22 $11.61BFY23 $12.14BFY24 $12.82BFY25 $13.64B

Net Income

-20.2% YoY

$746.8MFY 2025

FY22 $560.4MFY23 $691.5MFY24 $936.3MFY25 $746.8M

Operating Income

-2.2% YoY

$2.04BFY 2025

FY22 $1.34BFY23 $1.60BFY24 $2.09BFY25 $2.04B

EPS (Diluted)

-8.3% YoY

$9.84FY 2025

FY22 $5.85FY23 $7.42FY24 $10.73FY25 $9.84

Total Assets

+1.1% YoY

$17.48BFY 2025

FY22 $16.93BFY23 $16.89BFY24 $17.29BFY25 $17.48B

Total Debt

+8.7% YoY

$10.27BFY 2025

FY22 $8.92BFY23 $8.39BFY24 $9.45BFY25 $10.27B

Op. Cash Flow

-6.7% YoY

$1.89BFY 2025

FY22 $1.56BFY23 $2.06BFY24 $2.02BFY25 $1.89B

Free Cash Flow

-10.6% YoY

$1.31BFY 2025

FY22 $961.1MFY23 $1.49BFY24 $1.47BFY25 $1.31B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$13.64B +6.5%	$12.82B +5.6%	$12.14B +4.6%	$11.61B -0.1%	$11.62B +0.6%	$11.55B
Net Income	$746.8M -20.2%	$936.3M +35.4%	$691.5M +23.4%	$560.4M -42.7%	$978.5M +26.5%	$773.6M
Operating Income	$2.04B -2.2%	$2.09B +30.4%	$1.60B +19.7%	$1.34B -25.5%	$1.80B +6.1%	$1.69B
EPS (Diluted)	$9.84 -8.3%	$10.73 +44.6%	$7.42 +26.8%	$5.85 -34.3%	$8.90 +41.0%	$6.31
Total Assets	$17.48B +1.1%	$17.29B +2.3%	$16.89B -0.2%	$16.93B -1.1%	$17.12B +0.8%	$16.99B
Total Debt	$10.27B +8.7%	$9.45B +12.6%	$8.39B -6.0%	$8.92B +0.2%	$8.91B +10.2%	$8.09B
Operating Cash Flow	$1.89B -6.7%	$2.02B -1.8%	$2.06B +31.6%	$1.56B -19.0%	$1.93B -2.4%	$1.98B
Free Cash Flow	$1.31B -10.6%	$1.47B -1.6%	$1.49B +55.1%	$961.1M -25.5%	$1.29B -1.2%	$1.30B

Get alerted when DVA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DAVITA INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of DVA

BERKSHIRE HATHAWAY INC
$6.4B28,880,209 sh
BlackRock, Inc.
$547.5M2,460,987 sh
VANGUARD CAPITAL MANAGEMENT LLC
$467.5M2,101,425 sh
MORGAN STANLEY
$356.3M1,601,710 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$306.6M1,377,914 sh
STATE STREET CORP
$294.3M1,323,019 sh
Invesco Ltd.
$269.6M1,211,917 sh
DIMENSIONAL FUND ADVISORS LP
$253.1M1,137,814 sh
Neuberger Berman Group LLC
$205.8M925,579 sh
LSV ASSET MANAGEMENT
$202.1M908,389 sh

Fund	Value	Shares
BERKSHIRE HATHAWAY INC	$6.4B	28,880,209
BlackRock, Inc.	$547.5M	2,460,987
VANGUARD CAPITAL MANAGEMENT LLC	$467.5M	2,101,425
MORGAN STANLEY	$356.3M	1,601,710
VANGUARD PORTFOLIO MANAGEMENT LLC	$306.6M	1,377,914
STATE STREET CORP	$294.3M	1,323,019
Invesco Ltd.	$269.6M	1,211,917
DIMENSIONAL FUND ADVISORS LP	$253.1M	1,137,814
Neuberger Berman Group LLC	$205.8M	925,579
LSV ASSET MANAGEMENT	$202.1M	908,389

Companies Similar to DVA

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

IQV

IQVIA HOLDINGS INC.

AI score

Very similar · 8 shared holders

NORDEA INVESTMENT MANAGEMENT AB Candriam S.C.A.Robeco Institutional Asset Management B.V.

ZBH

ZIMMER BIOMET HOLDINGS, INC.

AI score

Very similar · 11 shared holders

Holocene Advisors, LP LSV ASSET MANAGEMENT Tredje AP-fonden

BDX

BECTON DICKINSON & CO

AI score

Similar quality profile · 12 shared holders

NORDEA INVESTMENT MANAGEMENT AB STOREBRAND ASSET MANAGEMENT AS CAISSE DE DEPOT ET PLACEMENT DU QUEBEC

UHS

UNIVERSAL HEALTH SERVICES INC

AI score

Similar quality profile · 25 shared holders

LSV ASSET MANAGEMENT NORDEA INVESTMENT MANAGEMENT AB Susquehanna Portfolio Strategies, LLC

DGX

QUEST DIAGNOSTICS INC

AI score

Similar quality profile · 14 shared holders

NORDEA INVESTMENT MANAGEMENT AB Candriam S.C.A.Susquehanna Portfolio Strategies, LLC

THC

TENET HEALTHCARE CORP

AI score

Similar quality profile · 15 shared holders

LSV ASSET MANAGEMENT WEDGE CAPITAL MANAGEMENT L L P/NC BI Asset Management Fondsmaeglerselskab A/S

ALGN

ALIGN TECHNOLOGY INC

AI score

Similar quality profile · 14 shared holders

LSV ASSET MANAGEMENT CAISSE DE DEPOT ET PLACEMENT DU QUEBEC National Philanthropic Trust

COO

COOPER COMPANIES, INC.

AI score

Similar quality profile · 13 shared holders

Gates Capital Management, Inc.Holocene Advisors, LP Susquehanna Portfolio Strategies, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put DVA on your watchlist

Track score changes the day DAVITA INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is DVA a good stock to buy?

13F Pro's AI-powered analysis of DAVITA INC. (DVA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DVA are available on the DVA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. DVA is classified as a large company.

Which hedge funds own DVA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DVA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DAVITA INC.'s investment landscape.